Cytidine 3',5'-monophosphate (cyclic CMP). II. Initiation of leukemia L-1210 cell growth in vitro.
D000818:Animals; D002455:Cell Division / Q000187:drug effects*; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000494:pharmacology; D006152:Cyclic GMP / Q000494:pharmacology; D003597:Cytosine Nucleotides / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D007939:Leukemia L1210 / Q000378:metabolism*; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009712:Nucleotides, Cyclic / Q000494:pharmacology*; D014176:Protein Biosynthesis / Q000187:drug effects; D013329:Structure-Activity Relationship; D013696:Temperature; D013997:Time Factors; D014500:Uracil Nucleotides / Q000494:pharmacology
D003597:Cytosine Nucleotides; D009363:Neoplasm Proteins; D009712:Nucleotides, Cyclic; D014500:Uracil Nucleotides; D000242:Cyclic AMP; D006152:Cyclic GMP